NEW YORK (GenomeWeb News) – Molecular diagnostic testing firm Response Genetics today reported a 13 percent drop year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2013, the Los Angeles-based company recorded revenues of $4.8 million, down from $5.5 million in Q4 2012. While Response DX test revenues were up 3 percent year over year, pharmaceutical client revenues were down 35 percent year over year, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.